ResultsIQ

ResultsIQ › Latest results › Health X Platform Limited

Health X Platform Limited Q4 FY25 earnings call summary

NSE: HEALTHX · BSE: 533259

Earnings call of 12 Jun 2025, summarised by AI from the filing.

RetailerShakti revenue nearly doubled to ₹941 cr in FY25; management guides 100% B2C growth in FY26.

Key takeaways

  1. RetailerShakti growth RetailerShakti revenue nearly doubled to ₹941 cr in FY25 from ₹489 cr in FY24.
  2. B2C guidance Management estimates 100% growth in SastaSundar B2C revenue for FY26.
  3. Growth driver RetailerShakti B2B business nearly doubled revenue, driving overall growth.
  4. Risk Regulatory uncertainty on e-pharmacy remains a key risk.

Original filing on BSE

Health X Platform Limited Q1 FY27 results

As filed: Revenue ₹447 cr, EBITDA −₹8.4 cr, PAT ₹2.0 cr, EBITDA margin -1.9%.

Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹447 cr). Scored once a year-earlier consolidated quarter exists.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹374 cr, EBITDA −₹25.2 cr, PAT −₹13.0 cr, EBITDA margin -6.7%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹374 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +3.6% in 30 days (Nifty 500: +1.5%).

Past price moves after results do not indicate future moves. Not a recommendation.

Health X Platform Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.